Sean Stalfort
Direktor/Vorstandsmitglied bei TAYSHA GENE THERAPIES, INC.
Vermögen: 9 Mio $ am 30.04.2024
Profil
Mr. Sean Stalfort is an Independent Director at Taysha Gene Therapies, Inc., an Independent Director at Acumen Pharmaceuticals, Inc., a Chairman and CEO at PBM Capital Group LLC, a Founding Partner at Octagon Partners LLC and a Partner at Octagon Finance LLC.
He is on the Board of Directors at Taysha Gene Therapies, Inc., Acumen Pharmaceuticals, Inc., Verrica Pharmaceuticals, Inc., Novartis Gene Therapies Switzerland GmbH, Baxis Pharmaceuticals, Inc., PBM Pharmaceuticals, Inc., SalioGen Therapeutics, Inc., Tolerion, Inc., Vetana Animal Health, Inc. and Xalud Therapeutics, Inc. Mr. Stalfort was previously employed as a Founding Partner by Benevolent Capital Partners LLC (Private Equity), a Vice President by Greenwich Capital Holdings, Inc., a Senior Underwriter by RBS Securities, Inc., an Investment Banking Associate by CS First Boston Pacific, Inc., a Senior Vice President-Capital Markets by Enterprise Mortgage Acceptance Co. LLC, a Senior Vice President by Koch Financial Corp.
/Municipal Lending Business/, an Executive Vice President-New Business Development by PBM Products LLC, and a Founding Partner by Ravelin Capital Group LLC.
He also served on the board at Dova Pharmaceuticals, Inc., Candel Therapeutics, Inc., Genapure Corp., Perrigo Co. and Quantapore, Inc. He received his undergraduate degree from Brown University and an undergraduate degree from the University of Massachusetts.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.05.2024 | 1 982 891 ( 1,06% ) | 5 Mio $ | 30.04.2024 | |
| 31.03.2024 | 462 110 ( 1,09% ) | 3 Mio $ | 30.04.2024 | |
| 08.04.2024 | 303 919 ( 0,51% ) | 969 502 $ | 30.04.2024 |
Aktive Positionen von Sean Stalfort
| Unternehmen | Position | Beginn |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 01.12.2015 |
| ACUMEN PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.10.2018 |
| TAYSHA GENE THERAPIES, INC. | Direktor/Vorstandsmitglied | 21.06.2023 |
| Octagon Partners LLC | Corporate Officer/Principal | - |
PBM Pharmaceuticals, Inc.
 PBM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PBM Pharmaceuticals, Inc. manufactures pharmaceutical products. The private company is based in Charlottesville, VA. | Direktor/Vorstandsmitglied | - |
| Novartis Gene Therapies Switzerland GmbH | Direktor/Vorstandsmitglied | - |
| Vetana Animal Health, Inc. | Direktor/Vorstandsmitglied | - |
| Baxis Pharmaceuticals, Inc. | Direktor/Vorstandsmitglied | - |
SalioGen Therapeutics, Inc.
 SalioGen Therapeutics, Inc. BiotechnologyHealth Technology SalioGen Therapeutics, Inc. is a genetic medicine company based in Cambridge, MA. The company is advancing the Exact DNA Integration Technology (EDIT) platform, which is a mammal-derived genome engineering technology for use in potentially curative non-viral gene therapy. SalioGen Therapeutics has launched Gene Coding, a genetic medicine technology, to develop durable, broadly applicable genetic medicines using its EDIT platform. The company's mission is to transform the treatment paradigm for patients with inherited disorders. Jason F. Cole has been the CEO of the company since 2023. | Direktor/Vorstandsmitglied | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Sean Stalfort
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░ ░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░ ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Sean Stalfort
| Brown University | Undergraduate Degree |
| University of Massachusetts | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| ACUMEN PHARMACEUTICALS, INC. | Health Technology |
| CANDEL THERAPEUTICS, INC. | Health Technology |
| VERRICA PHARMACEUTICALS INC. | Health Technology |
| TAYSHA GENE THERAPIES, INC. | Health Technology |
| Private Unternehmen | 22 |
|---|---|
Perrigo Co.
 Perrigo Co. Pharmaceuticals: MajorHealth Technology Perrigo Co. manufactures, distributes and markets pharmaceutical and nutritional products. The company was founded in 1887 and is headquartered in Allegan, MI. | Health Technology |
NatWest Markets Securities, Inc.
 NatWest Markets Securities, Inc. Investment Banks/BrokersFinance Founded in 1985, NatWest Markets Securities, Inc. is a financial services and brokerage firm headquartered in Stamford, Connecticut. The firm is a subsidiary of RBS Holdings USA, Inc. and their ultimate parent is the Royal Bank of Scotland Plc (LSE: RBS). The firm was formerly known as RBS Securities, Inc., RBS Greenwich Capital, and Greenwich Capital Markets, Inc. NatWest is an institutional fixed-income firm that provides a full range of debt capital markets services to both those seeking to raise capital and those seeking to invest it. The firm is an industry leader in the U.S. Treasury, agency and MBS markets and in providing real estate and asset-backed financing to their clients. NatWest also provides futures brokerage services and trade strategies to select clients. | Finance |
| Octagon Partners LLC | |
| Greenwich Capital Holdings, Inc. | Finance |
PBM Products LLC
 PBM Products LLC Food: Meat/Fish/DairyConsumer Non-Durables PBM Products LLC entered into an exclusive supply arrangement to introduce the first private-label (store-brand) infant formulas in the United States. Today store-brand infant formulas have become increasingly important to retailers, and an affiliate company, PBM Nutritionals LLC manufactures state-of-the-art formulas for PBM Products and its retail partners. Whether a store brand carries its own retail name or is part of a wholesaler's private-label program, store-brand products give retailers a way to make a higher margin, differentiate themselves from the competition, and win the loyalty of customers. It believes their extensive private-label product lines are helping some of the largest retailers in America accomplish their business goals. In turn, their retail partners are helping them to accomplish its mission. PBM partners with leading food and drug retailers to provide high-quality, competitively priced products to customers labeled under the store brands of companies such as Wal-Mart, Target, Kroger, Loblaws, and Walgreens. | Consumer Non-Durables |
| CS First Boston Pacific, Inc. | |
Genapure Corp.
 Genapure Corp. Miscellaneous Commercial ServicesCommercial Services Genapure Corp. provided outsourced environmental food, and pharmaceutical testing services. Its services included groundwater monitoring, stream surveys, soil testing, swimming pool testing and dairy product testing. The company was founded on January 30, 2006 and was headquartered in Boca Raton, FL. | Commercial Services |
Enterprise Mortgage Acceptance Co. LLC
 Enterprise Mortgage Acceptance Co. LLC Miscellaneous Commercial ServicesCommercial Services Enterprise Mortgage Acceptance Co. LLC provides capital and financing options for equipment financing and business loans. The private company is based in Westport, CT and has subsidiaries in the United States. | Commercial Services |
| Koch Financial Corp. /Municipal Lending Business/ | Finance |
Benevolent Capital Partners LLC (Private Equity)
 Benevolent Capital Partners LLC (Private Equity) Investment ManagersFinance Benevolent Capital Partners LLC (Private Equity) (Benevolent Capital) is a private equity and venture capital firm founded in 2005 by Brett M. Johnson and Grant D. Johnson. The firm is headquartered in Charlottesville, Virginia. | Finance |
PBM Capital Group LLC
 PBM Capital Group LLC Investment ManagersFinance PBM Capital Group LLC (PBM Capital Group) is a private equity and venture capital firm founded in 2010 by Paul B. Manning. The firm is headquartered in Charlottesville, Virginia. | Finance |
PBM Pharmaceuticals, Inc.
PBM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology PBM Pharmaceuticals, Inc. manufactures pharmaceutical products. The private company is based in Charlottesville, VA. | Health Technology |
Tolerion, Inc.
 Tolerion, Inc. Pharmaceuticals: MajorHealth Technology Tolerion, Inc. operates as a clinical-stage biopharmaceutical firm. It develops and commercializes therapeutics. The firm provides TOL-3034 and TOL-3052 to treat myasthenia gravis and neuromyelitis optica. The company was founded by Lawrence J. Steinman and is headquartered in South San Francisco, CA. | Health Technology |
Xalud Therapeutics, Inc.
 Xalud Therapeutics, Inc. BiotechnologyHealth Technology Xalud Therapeutics, Inc. develops novel therapies with several promising therapeutic programs for inflammatory. The firm offers XT-101, a single dosage injection that stops disease progression, eliminates neuropathic pain, and reverses paralysis. It also researches on the applicability of XT-101 for multiple sclerosis and amyotrophic lateral sclerosis. The company was founded by John Forsayeth and Linda Watkins and is headquartered in San Francisco, CA. | Health Technology |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
Quantapore, Inc.
 Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA. | Health Technology |
Octagon Finance LLC
 Octagon Finance LLC Financial ConglomeratesFinance Octagon Finance LLC provides financial services. The private company is based in Durham. | Finance |
| Novartis Gene Therapies Switzerland GmbH | |
SalioGen Therapeutics, Inc.
SalioGen Therapeutics, Inc. BiotechnologyHealth Technology SalioGen Therapeutics, Inc. is a genetic medicine company based in Cambridge, MA. The company is advancing the Exact DNA Integration Technology (EDIT) platform, which is a mammal-derived genome engineering technology for use in potentially curative non-viral gene therapy. SalioGen Therapeutics has launched Gene Coding, a genetic medicine technology, to develop durable, broadly applicable genetic medicines using its EDIT platform. The company's mission is to transform the treatment paradigm for patients with inherited disorders. Jason F. Cole has been the CEO of the company since 2023. | Health Technology |
| Baxis Pharmaceuticals, Inc. | |
| Vetana Animal Health, Inc. | |
| Ravelin Capital Group LLC |
